Sign up to save your podcasts
Or
Share The NASH Epidemic: Highlights from the AMCP 2023 Symposium
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
CME credits: 0.25
Valid until: 27-04-2024
Claim your CME credit at https://reachmd.com/programs/cme/the-nash-epidemic-highlights-from-the-amcp-2023-symposium/14957/
Nonalcoholic steatohepatitis (NASH) is an epidemic with enormous health and economic implications. Join us for our chairman’s perspective on best practices to identify, screen, and refer patients. Dr. Mazen Noureddin also examines some of the emerging therapeutics that may change your approach to NASH.
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 27-04-2024
Claim your CME credit at https://reachmd.com/programs/cme/the-nash-epidemic-highlights-from-the-amcp-2023-symposium/14957/
Nonalcoholic steatohepatitis (NASH) is an epidemic with enormous health and economic implications. Join us for our chairman’s perspective on best practices to identify, screen, and refer patients. Dr. Mazen Noureddin also examines some of the emerging therapeutics that may change your approach to NASH.
=